This website uses cookies for usage measurement and traffic analysis purposes.
By clicking the "Agree" button or continuing to browse this site, you consent to the use of cookies.
For more details, please refer to the Privacy Policy
(opens in a new window).
| Department | Department of Experimental Therapeutics |
|---|---|
| Specialized Treatment | Early drug development |
Dr. Koyama graduated from Kanazawa University School of Medicine in 2006. After completing the residency at Kishiwada Tokusyukai Hospital and the fellowship of hematology and oncology at Kameda General Hospital, he joined the department of medical oncology at Kameda General Hospital as an attending physician in 2012. In 2016, he joined the department of experimental therapeutics at National Cancer Center Hospital as a fellow in 2016. In 2018, after completing the training in early drug development and translational research, he became an attending physician of the department of experimental therapeutics at National Cancer Center Hospital. Current position from April 2022. He is primarily involved in early drug development and TR.
Traslational research, Precision oncology
| Apr/2022-Present | Head of Physician, Department of Experimental Therapeutics, National Cancer Center Hospital |
| Apr/2018-Mar/2022 | Attending Physician, Department of Experimental Therapeutics, National Cancer Center Hospital |
| Apr/2016-Mar/2016 | Fellow, Department of Experimental Therapeutics, National Cancer Center Hospital |
| Apr/2011-Mar/2016 | Attending Physician, Department of Medical Oncology, Kameda Medical Center |
| Apr/2008-Mar/2011 | Fellow, Department of Medical Oncology, Kameda Medical Center |
Medical Oncology, Heamatology
Board Certified Medical Oncology, Japanese Society of Medical Oncology
Board Certified Haematologist of Japanese Society of Haematology
Board Certified Member of the Japanese Society of Internal Medicine
